Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility

被引:35
作者
Olsen, GW
Burlew, MM
Marshall, JC
Burris, JM
Mandel, JH
机构
[1] 3M Co, Dept Med, St Paul, MN 55144 USA
[2] Ingenix Employer Grp, New Haven, CT USA
关键词
D O I
10.1097/01.jom.0000135546.70469.87
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The observed to expected episodes of care experience of 652 employees at a fluorochemical (perfluorooctanesulonyl fluoride) production facility was compared with 659 film plant (nonfluorochemical) employees at the same site (Decatur, AL). Episodes of care were defined by a hierarchical analysis of health claims data from 1993 through 1998. The age- and sex-adjusted expected number of episodes of care was calculated from the company's U.S. manufacturing workforce. For a priori interests, the observed to expected episodes of care ratios were comparable for fluorochemical and film plant employees for liver tumors or diseases, bladder cancer, thyroid and lipid metabolism disorders, and reproductive, pregnancy, and perinatal disorders and higher for biliary tract disorders and cystitis recurrence. Non-a priori associations among the fluorochemical plant workers included benign colon polyps, malignant colorectal tumors, and malignant melanoma.
引用
收藏
页码:837 / 846
页数:10
相关论文
共 46 条
[1]   Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility [J].
Alexander, BH ;
Olsen, GW ;
Burris, JM ;
Mandel, JH ;
Mandel, JS .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2003, 60 (10) :722-729
[2]   Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol;: peroxisome proliferation and mitochondrial biogenesis [J].
Berthiaume, J ;
Wallace, KB .
TOXICOLOGY LETTERS, 2002, 129 (1-2) :23-32
[3]  
BURRIS JM, AR2261086 EPA
[4]   Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months [J].
Butenhoff, J ;
Costa, G ;
Elcombe, C ;
Farrar, D ;
Hansen, K ;
Iwai, H ;
Jung, R ;
Kennedy, G ;
Lieder, P ;
Olsen, G ;
Thomford, P .
TOXICOLOGICAL SCIENCES, 2002, 69 (01) :244-257
[5]  
Case MT, 2001, INT J TOXICOL, V20, P101
[6]   Urinary bladder carcinogenesis [J].
Cohen, SM .
TOXICOLOGIC PATHOLOGY, 1998, 26 (01) :121-127
[7]  
Dang D K, 1996, Med Interface, V9, P122
[8]  
Dang D K, 1996, Med Interface, V9, P118
[9]  
DIEM K, 1967, DOCUMENTA GEIGY SCI
[10]   CONFIDENCE LIMITS ON RATIO OF 2 POISSON VARIABLES [J].
EDERER, F ;
MANTEL, N .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1974, 100 (03) :165-167